In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Laxoberal Drug Master File in Korea (Laxoberal KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Laxoberal. The MFDS reviews the Laxoberal KDMF as part of the drug registration process and uses the information provided in the Laxoberal KDMF to evaluate the safety and efficacy of the drug.
After submitting a Laxoberal KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Laxoberal API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Laxoberal suppliers with KDMF on PharmaCompass.